Comprehensive Review of Psychiatry 2019

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .

Please note that there are no CME points or certificate associated with this course

Format : 45 Video Files (.mp4 format) + 2 PDF File.

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Oakstone Publishing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation

Oakstone Publishing designates this enduring material for a maximum of 40.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact hours: 40.5
The contact hours are inclusive of 3.75 hours of pharmacotherapeutics.

Date of Original Release: November 30, 2019
Date Credits Expire: November 30, 2022

CME credit is awarded upon successful completion of a course evaluation and a post-test.

The American Board of Psychiatry and Neurology has reviewed the Comprehensive Review of Psychiatry and has approved this program as part of a comprehensive self-assessment program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.

Unique Learning Objectives

• At the conclusion of this CME activity, you will be better able to:
• Describe interventions and treatments for opioid use disorder
• Differentiate between major depressive disorder and bipolar disorder
• Summarize the techniques used in motivational interviewing
• Outline medical-psychiatric co-morbid disorders and their clinical management
• Summarize the methods used for treatment-resistant depression
• Differentiate among generalized anxiety disorder, panic disorder, and social anxiety disorder
• Explain the diagnosis and management of age-related cognitive decline
• Discuss the diagnosis and treatment of ADHD and related disorders
• List effective and evidence-based anti-depressants and their efficacy
• Explain the characteristics of burnout
• Intended Audience

This activity is intended for psychiatrists or psychiatry residents.

Topics/Speaker:

Approach to the Patient

Final Common Brain Pathways of Neuropsychiatric Symptoms – David Silberweig, MD
Disorders

• Schizophrenia – Oliver Freudenreich, MD, FACLP
• Depression – Nassir Ghaemi, MD, MPH
• Bipolar Illness: Diagnosis – Nassir Ghaemi, MD, MPH
• The Dimensions of Personality – John M. Oldham MD
• Update on Anxiety Disorders – Mark H. Pollack, MD
• Obsessive-Compulsive Disorders – Wayne Goodman, MD
• Impulse Control and Related Disorders – Emil F. Coccaro, MD
• Body Dysmorphic Disorder – Katharine A. Phillips, MD
• Diagnosis and Treatment of Age-Related Cognitive Decline – Gary Small, MD
• Catatonia – Scott R. Beach, MD
• Eating Disorders – Harry A. Brandt, MD
• Posttraumatic Stress Disorder and Stress-Related Syndromes – Robert J. Ursano MD
• Molecular Mimicry, Autoimmunity, and Psychopathology – Sheldon Benjamin, MD
• Substance Use Disorders: Tobacco/Nicotine – Hasmeena Kathuria, MD
• Substance Use Disorders: Alcohol – Grace Chang, MD, MPH
• Opioid Use Disorder and Long-Term Opioid Therapy – Dustin Patil, MD
• Substance Use Disorders: Cannabis – Arthur Robin Williams, MD, MBE
• Insomnia – Karl Doghramji, MD
• Pain and Somatic Symptom Disorder in Psychiatry – Robert M. McCarron, DO
• Somatic Symptom Disorders – Joel E. Dimsdale, MD
• Suicide – Mark A. Schechter, MD
• Post Partum Disorders – Marlene P. Freeman, MD

Child and Adolescent Psychiatry

• Integrative Approaches to ADHD Management Across the Lifespan: Children, Adolescents, and Adults – Anthony L. Rostain, MD
• ADHD and Stimulants – Timothy E. Wilens, MD
• Anxiety Disorders and Depression in Children and Adolescents – John Sargent, MD

Treatments: Psychopharmacologic

• MoodStabilizers: Second Messenger Modifiers – Nassir Ghaemi, MD, MPH
• Antidepressants: Monoamine Agonists – Nassir Ghaemi, MD, MPH
• Antipsychotic Drug Treatment of Schizophrenia – Jeffrey A. Lieberman, MD
• Anxiolytics – Edward Silberman, MD
• Substance Use Disorder Psychopharmacology, Overview and Updates – Dustin Patil, MD
• Practical Aspects of Prescribing Stimulant Medications – Anthony L. Rostain, MD

Treatments: Psychotherapy

• Cognitive Behavioral Therapy – Stefan G. Hofmann, PhD
• Brief Psychodynamic and Interpersonal Therapy – Mark A. Schechter, MD
• Motivational Interviewing – Joji Suzuki, MD
• Family Therapy – John Sargent, MD
• Positive Psychiatry – Dilip Jeste, MD
• Treatments: Brain Stimulation Therapies
• Treating Treatment Resistant Depression – Stephen Seiner, MD
• Treatment-Resistant Depression – David L. Dunner MD, FACPsych

Medical Psychiatry

• Clinical Challenge of Integrating Medical and Psychiatric Care – Paul Summergrad, MD
• Integrating Medical and Psychiatric Care – Paul Summergrad, MD
• Ethical and Legal Issues
• Burnout – Carol A. Bernstein, MD
• Involuntary Care and Capacity and Guardianship – Rebecca Weintraub Brendel MD, JD
• Risk Assessment for Violence – Phillip J. Resnick, MD
• Ethics & Professionalism – Laura B. Dunn, MD